Pneumovax 23 is a pneumococcal vaccine designed for active immunization to prevent pneumococcal disease caused by the 23 serotypes contained in the vaccine. It is approved for use in individuals aged 50 years or older and those aged 2 years and above who are at increased risk for pneumococcal disease.
Key FeaturesUsed for the prevention of pneumococcal disease in at-risk populations.
Typical User/Industry ProfileHealthcare providers, hospitals, clinics.
About the BrandMerck is a leading pharmaceutical company known for its innovative vaccines and commitment to public health.